2016•Annals of the Rheumatic DiseasesRequires access

FRI0080 Effects of IL-6 Receptor Inhibition Therapy on The Serum Levels of IL-33 and IL-6 in Patients with Rheumatoid Arthritis

In Ah Choi, S.J. Lee, W. Park, Soo‐An Park, Seung Cheol Shim, Han Joo Baek, Dae‐Hyun Yoo, H.A. Kim, S.K. Lee, Y.J. Lee, Y.E. Park, Hoon‐Suk Cha, E.Y. Lee, E.B. Lee, Yaodong Song

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Rheumatoid arthritis, Tocilizumab, Internal medicine, Receptor, Gastroenterology, Interleukin 10, Interleukin

Back to paper search Browse research topics Original source

FRI0080 Effects of IL-6 Receptor Inhibition Therapy on The Serum Levels of IL-33 and IL-6 in Patients with Rheumatoid Arthritis — Research Paper | ScholarLens